Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis (Q51747614)

11 April 2018

title

Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis (English)

1 reference

11 April 2018

0 references

1 reference

1 reference

11 April 2018

author name string

Hideki Niwa

1 reference

11 April 2018

Motoko Sasaki

1 reference

11 April 2018

Joji Haratake

1 reference

11 April 2018

Takahiko Kasai

1 reference

11 April 2018

Kazuyoshi Katayanagi

1 reference

11 April 2018

Hiroshi Kurumaya

1 reference

11 April 2018

Shinji Masuda

1 reference

11 April 2018

You Zen

1 reference

11 April 2018

Akio Uchiyama

1 reference

11 April 2018

Atsuo Miwa

1 reference

11 April 2018

Katsuhiko Saito

1 reference

11 April 2018

Yoshiko Sudo

1 reference

11 April 2018

Yasuni Nakanuma

1 reference

11 April 2018

publication date

4 July 2007

1 reference

11 April 2018

published in

Hepatology Research

1 reference

11 April 2018

volume

1 reference

11 April 2018

issue

1 reference

11 April 2018

page(s)

923-931

1 reference

11 April 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2007.00150.X

10.1111/J.1872-034X.2007.00150.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

release_skacvoelsvamlkuy6v72fo46ce

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/skacvoelsvamlkuy6v72fo46ce

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 April 2018